Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.265, 2000-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PEG INF-α-2a/ribavirin cost effective for mild-chronic hep C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
Access to resources
Recommend
Infant hep B, Hib vaccines both highly cost effective
Inpharma, Vol. 1, Iss. 1504, 2005-01 ,pp. :
US hep A vaccination programme successful
Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. :
Hep C patients willing to accept side effects to get rid of virus
Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. :
Clevudine lays claim to the crown in chronic hep B
Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. :